在CFTR中通过CRISPR-Cas9基因编辑进行深层内拼接突变的分子和功能纠正
Amy J Walker1, Carina Graham1, Miriam Greenwood1
1Genetics and Genomic Medicine Department, UCL Great Ormond Street Institute of Child Health, London, UK.
Molecular therapy. Methods & clinical development
|November 29, 2023
概括
基因编辑成功地纠正了气道细胞中常见的囊性纤维化突变. 这种方法恢复了CFTR基因功能,为治疗由深层内突变引起的遗传疾病提供了潜力.
科学领域:
- 分子生物学分子生物学
- 基因工程是一种基因工程.
- 细胞生物学 细胞生物学
背景情况:
- 囊性纤维化 (CF) 是一种由CFTR基因突变引起的遗传疾病.
- 一种常见的CF突变 (3849+10kb C>T) 破坏了正确的CFTR mRNA拼接.
- 针对深层内基突变仍然是基因疗法的挑战.
研究的目的:
- 开发和测试一种基因编辑策略,以纠正3849+10kb的C>T CFTR突变.
- 在患者衍生细胞中恢复CFTR基因功能和蛋白质表达.
- 评估基因编辑方法的安全性和有效性.
主要方法:
- 使用CRISPR-Cas9核糖蛋白 (RNP) 复合体与双导向RNA (gRNA) 来切除突变.
- 使用非病毒性,受体向的纳米复合物向CF基底上皮细胞传递RNP.
- 在空气-液体界面培养中评估了CFTR mRNA拼接,蛋白质表达和电生理功能.
主要成果:
- 基因编辑方法成功切除了CF细胞中的3849+10kbC>T突变.
- 恢复了正规的CFTRmRNA拼接和CFTR蛋白质表达.
- 同时在气道上皮培养物中观察到电生理功能的恢复.
- 通过选择基因组部位的桑格测序,没有检测到非目标编辑.
结论:
- 通过CRISPR-Cas9调解的基因编辑可以纠正深度内源性CF突变.
- 非病毒纳米复合物输送促进了气道上皮细胞中的基因编辑.
- 这一策略对治疗CF和其他具有内基突变的遗传疾病具有前景.
相关概念视频
CRISPR
51.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.7K
Homologous Recombination
50.6K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.6K


